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Protein–protein interactionsd protein–protein interactions between the structural proteins of herpes simplex
virus type 1 (HSV-1) using a LexA yeast two-hybrid system. The majority of the capsid, tegument and
envelope proteins of HSV-1 were screened in a matrix approach. A total of 40 binary interactions were
detected including 9 out of 10 previously identiﬁed tegument–tegument interactions (Vittone, V.,
Diefenbach, E., Triffett, D., Douglas, M.W., Cunningham, A.L., and Diefenbach, R.J., 2005. Determination of
interactions between tegument proteins of herpes simplex virus type 1. J. Virol. 79, 9566–9571). A total of 12
interactions involving the capsid protein pUL35 (VP26) and 11 interactions involving the tegument protein
pUL46 (VP11/12) were identiﬁed. The most signiﬁcant novel interactions detected in this study, which are
likely to play a role in viral assembly, include pUL35–pUL37 (capsid–tegument), pUL46–pUL37 (tegument–
tegument) and pUL49 (VP22)–pUS9 (tegument–envelope). This information will provide further insights into
the pathways of HSV-1 assembly and the identiﬁed interactions are potential targets for new antiviral drugs.
© 2008 Elsevier Inc. All rights reserved.Introduction
The herpes simplex virion consists of four components that include
a double stranded DNA genome (152kb), capsid, tegument, and an
outer envelope (Roizman and Sears, 1996). The icosadeltahedral
capsid encloses the DNA genome and consists of 6 external proteins
pUL6, pUL18 (VP23), pUL19 (VP5), pUL25, pUL35 (VP26) and pUL38
(VP19C) (Roizman and Sears, 1996). The surrounding tegument
contains 22 proteins that include pUL4, pUL11, pUL13, pUL14, pUL16,
pUL17, pUL21, pUL36 (VP1/2), pUL37, pUL41, pUL46 (VP11/12), pUL47
(VP13/14), pUL48 (VP16), pUL49 (VP22), pUL51, pUL56, pUS2, pUS3,
pUS10, pUS11, ICP0, and ICP4 (Mettenleiter, 2004). The envelope
contains the 5 proteins, pUL20, pUL43, pUL45, pUL49A and pUS9
along with the 11 glycoproteins gpUL1 (gL), gpUL10 (gM), gpUL22
(gH), gpUL27 (gB), gpUL44 (gC), gpUL53 (gK), gpUS4 (gG), gpUS5 (gJ),
gpUS6 (gD), gpUS7 (gI) and gpUS8 (gE) (Mettenleiter, 2004).
Two pathways have been proposed for viral assembly and egress
from the host cell. The ﬁrst model for viral assembly and egress
involves the pathway of primary envelopment, de-envelopment and
secondary envelopment (Mettenleiter, 2002, 2004, 2006). After
assembly in the nucleus, the mature herpes simplex virus type 1
(HSV-1) nucleocapsid (capsid containing DNA genome) undergoes
primary envelopment through the inner nuclear membrane into the
perinuclear space. The enveloped particles are de-enveloped at the
outer nuclear membrane. Acquisition of inner tegument (pUL36,u (R.J. Diefenbach).
l rights reserved.pUL37 and pUS3) onto the capsid (which may possibly begin in the
nucleus (Bucks et al., 2007)) precedes secondary envelopment, and
acquisition of outer tegument (consisting primarily of pUL46, pUL47,
pUL48 and pUL49) and glycoprotein envelope, in or close to the Golgi.
The outer tegument and glycoprotein self-assemble within the
cytoplasm in a process that is independent from the addition of the
inner tegument to the capsid. Interaction between the capsid and
capsidless tegument structures appears to be essential to drive
secondary envelopment of the virus (Mettenleiter, 2006). Fully
assembled virions are ﬁnally released by exocytosis. A second pathway
for HSV assembly and egress has been recently proposed, suggesting
that nucleocapsids exit directly into the cytoplasm via damaged
nuclear pores before addition of tegument in the cytoplasm and
envelopment at the Golgi (Leuzinger et al., 2005; Wild et al., 2005).
This second pathway remains to be conﬁrmed by other laboratories.
The use of the yeast two-hybrid assay to deﬁne viral protein
interaction networks or interactomes (Diefenbach et al., 2005) has
been successfully undertaken for a number of herpesviruses
including the alphaherpesviruses HSV-1 (Vittone et al., 2005) and
Varicella zoster virus (VZV) (Uetz et al., 2006), the gammaherpes-
virus Epstein–Barr virus (Calderwood et al., 2007) and Kaposi’s
sarcoma-associated virus (Uetz et al., 2006; Rozen et al., 2008).
Knowledge of the viral interactome, particularly amongst structural
virion proteins, coupled with viral gene deletion and morphological
studies has led to an emerging picture of the protein–protein
interactions important for assembly and egress of HSV-1 and the
related alphaherpesvirus Pseudorabies virus (PrV) (Vittone et al.,
2005; Mettenleiter, 2006).
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using a library of the majority of the HSV-1 structural proteins from
the capsid, tegument and envelope. This represents an extension of a
partial screen using a library of 13 HSV-1 tegument proteins (Vittone
et al., 2005). A total of 31 new interactions were detected.
Results
Yeast two-hybrid analysis of the interaction of HSV-1 structural proteins
In this study we have cloned and expressed, in the LexA yeast
two-hybrid system, 6 of the external capsid proteins (pUL6, pUL18,
pUL19, pUL25, pUL35 and pUL38), 20 of the 22 tegument proteins
(pUL4, pUL11, pUL13, pUL14, pUL16, pUL17, pUL21, pUL36, pUL37,
pUL41, pUL46, pUL47, pUL48, pUL49, pUL51, pUL56, pUS2, pUS3,
pUS10 and pUS11) and 8 of the 16 envelope proteins (gM, gB, gC,
pUL45, gD, gI, gE and also pUS9) of HSV-1 (Table 1). All were cloned
into both Bait and Target vectors with the exception of pUL45 which
could only be cloned into Target vector (Table 1). Proteins ICP0 and
ICP4 were not included in the screen as they are minor components
of the tegument and probably perform purely regulatory rather than
structural roles (Yao and Courtney, 1989, 1992). The library of HSV-1
proteins were all full-length constructs with the following excep-
tions: pUL19 upper domain (UD) (aa 451–1054) (Bowman et al.,
2003), pUL36N (aa 1–1874) (Douglas et al., 2004), pUL36N1 (aa 1–
767) (Vittone et al., 2005), and the cytoplasmic tail of each envelope
protein (Table 1). Full-length pUL19 was previously found to notTable 1
Summary of HSV-1 structural proteins tested in the yeast two-hybrid assay
Structural HSV-1
protein
Gene size
(bp)
Mwt (Da) Virion
location
Essential
in cell
culture
pUL6 2031 74091 Capsid Yes
pUL18 (VP23) 957 34271 Capsid Yes
pUL19 (VP5) 4125 149084 Capsid Yes
pUL25 1743 62670 Capsid Yes
pUL35 (VP26) 339 12094 Capsid No
pUL38 (VP19C) 1398 50263 Capsid Yes
pUL4 600 21517 Tegument No
pUL11 291 10485 Tegument No
pUL13 1557 57196 Tegument No
pUL14 660 23933 Tegument No
pUL16 1122 40442 Tegument No
pUL17 2112 74582 Tegument Yes
pUL21 1608 57641 Tegument No
pUL36 (VP1/2) 9495 335821 Tegument Yes
pUL37 3372 129574 Tegument Yes
pUL41 1470 54918 Tegument No
pUL46 (VP11/12) 2157 78244 Tegument No
pUL47 (VP13/14) 2082 73791 Tegument No
pUL48 (VP16) 1473 54345 Tegument Yes
pUL49 (VP22) 906 32254 Tegument No
pUL51 735 25470 Tegument No
pUL56 705 25320 Tegument No
pUS2 876 32470 Tegument No
pUS3 1446 52834 Tegument No
pUS10 939 34055 Tegument No
pUS11 486 16692 Tegument No
gpUL10 (gM) 1442 51393 Envelope No
gpUL27 (gB) 2715 100292 Envelope Yes
gpUL44 (gC) 1536 54998 Envelope No
pUL45 519 18233 Envelope No
gpUS6 (gD) 1185 43347 Envelope Yes
gpUS7 (gI) 1173 41369 Envelope No
gpUS8 (gE) 1653 59093 Envelope No
pUS9 273 10026 Envelope No
NE, not expressed; AA, autoactivates; FL, full-length.
a Bait only size 22,634 Da. Target only size 11,833 Da.express in the yeast two-hybrid assay (Douglas et al., 2004). The
pUL19 UD contains the binding site for pUL35 and in the context of
the capsid structure is accessible for interactions with other viral
proteins (Bowman et al., 2003; Baker et al., 2006). The complete
gene (9495bp) encoding the large tegument protein pUL36 could not
be previously ampliﬁed in our laboratory (Douglas et al., 2004). As
such we have focused on the N-terminal two thirds of the protein, as
the majority of the C-terminus, except for the extreme C-terminal
end, is dispensable for viral function, as shown for PrV (Bottcher et
al., 2006; Lee et al., 2006; Bottcher et al., 2007; Coller et al., 2007).
For ease of cloning the single transmembrane spanning envelope
proteins were the focus of this study. Furthermore, the cytoplasmic
tails were chosen as they have been postulated to form the link
with the outer tegument proteins during secondary envelopment
(Mettenleiter et al., 2006). A similar approach using the LexA yeast
two-hybrid assay and the cytoplasmic tails of PrV glycoproteins has
been previously described (Fuchs et al., 2002). In addition, the
nature of the LexA yeast two-hybrid assay requires that interacting
proteins translocate to the nucleus for expression of the nutritional
reporter genes (Fashena et al., 2000). This is less likely if one of the
protein partners contains a transmembrane domain which restricts
it to the cytoplasm.
A yeast two-hybrid matrix screen (Diefenbach et al., 2005) testing
all possible binary combinations was then undertaken using the
library of HSV-1 structural proteins. A total of 40 interactions were
initially identiﬁed using a qualitative plate-based assay (Table 2).
These interactions included 6 capsid–capsid, 11 capsid–tegument, 5Yeast two-hybrid assay
Fragment expressed
(aa number)
Fragment
size (Da)
Bait fusion
size (Da)a
Target fusion
size (Da)a
FL 96725 85924
FL 56904 46104
451–1054 65103 87737 76936
FL AA 74503
FL 34728 23927
FL AA 62096
FL 44151 33350
FL 33119 22318
FL 79830 (NE) 69029
FL AA 35766
FL AA 52275
FL AA 86415
FL AA 69474
1–1874, 1–767 199564,
81008
222198 92839
FL 143208 132407
FL 77552 66751
FL 100878 90077
FL 96425 85624
1–411, FL 68690 AA 66178
FL 54888 44087
FL 48104 37303
FL 47954 37153
FL 55104 44303
FL AA 64667
FL AA 45888
FL 39326 28525
343–473 15225 AA 27058
796–904 12281 34915 24114
501–511 1467 24101 13300 (NE)
49–172 13334 25167
364–394 3839 26473 15672 (NE)
296–390 10279 32913 22112
447–550 11561 AA 23394 (NE)
1–64 7341 29975 19174 (NE)
Table 2
Yeast two-hybrid matrix screen for binary interactions of HSV-1 structural proteinsa
Positive interactions (shaded) were observed as blue colonies with + indicating lightest blue and +++ the darkest blue. No growth (−) indicates a negative interaction.
AA, autoactivation; NE, not expressed; N, amino acids 1–1874; N1, amino acids 1–767; CT, cytoplasmic domain; −AD, minus activation domain (amino acids 412–490); UD, upper domain (amino acids 451–1054).
a Interactions were assessed using a qualitative in vivo plate assay (at day 3) with readout being expression of the reporter genes LEU2 and lacZ.
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Table 3
Summary of quantitative liquid β-galactosidase assay for yeast two-hybrid positive
interactions
Interaction β-galactosidase
activity
Plate score
No insert/no insert
(negative control)
6±2 –
p53/large T-antigen
(positive control)
2274±258 3 plus
Capsid/capsid
pUL18/pUL18 10±5 1 plus
pUL18/pUL38 108±28 3 plus
pUL35/pUL18 1422±357 3 plus
pUL35/pUL19 531±48 1 plus
pUL35/pUL25 390±119 1 plus
pUL35/pUL38 1510±203 2 plus
Capsid/tegument
pUL19/pUL16 18±4 2 plus
pUL19/pUL21 264±16 3 plus
pUL19/pUL48 31±15 1 plus
pUL35/pUL11 12±2 1 plus
pUL35/pUL14 49±15 2 plus
pUL35/pUL16 9±2 2 plus
pUL35/pUL21 55±10 2 plus
pUL35/pUL37 1180±32 3 plus
pUL35/pUL48 172±24 2 plus
pUL35/pUL51 129±38 3 plus
pUL35/pUS3 59±2 1 plus
Tegument/capsid
pUL37/pUL38 25±6 1 plus
pUL46/pUL18 1431±50 3 plus
pUL46/pUL19 22±9 1 plus
pUL46/pUL25 50±6 1 plus
pUL46/pUL38 50±6 1 plus
Tegument/tegument
pUL4/pUL56 8±2 1 plus
pUL11/pUL16 1482±127 3 plus
pUL36/pUL37 135±28 3 plus
pUL36/pUL48 76±16 3 plus
pUL37/pUL36 87±12 2 plus
pUL37/pUL37 448±28 3 plus
pUL46/pUL21 3±2 1 plus
pUL46/pUL37 67±9 3 plus
pUL46/pUL48 79±23 3 plus
pUL46/pUL49 74±3 1 plus
pUL46/pUS3 25±3 3 plus
pUL46/pUS10 15±1 1 plus
pUL49/pUL48 1483±164 3 plus
pUL49/pUL49 147±17 3 plus
pUS11/pUS11 394±20 3 plus
Tegument/envelope
pUL46/gM 162±17 2 plus
Envelope/tegument
pUS9/pUL49 210±38 3 plus
Envelope/envelope
gB/gB 263±44 3 plus
350 J.H. Lee et al. / Virology 378 (2008) 347–354tegument–capsid, 15 tegument–tegument, 1 tegument–envelope,
1 envelope–tegument, and 1 envelope–envelope (Table 2). Within the
tegument–tegument interactions 9 have been previously described in
our laboratory (Vittone et al., 2005). Only the interaction of pUL36
with pUL37, was found in both orientations (Table 2). For pUL35 and
pUL46 a high number of interactions were observed as baits but none
as targets (Table 2). The inﬂuence of the fusion partner on correct
folding of the fused viral protein may explain why the pUL35 and
pUL46 interactions work in only one orientation. A high proportion
(11) of bait constructs were found to autoactivate, which is a general
observation of the yeast two-hybrid approach (Fashena et al., 2000),
and hence could not be tested in the yeast two-hybrid screen
(Table 1). In the case of pUL48, amino acids 1–411 (which lacked the
C-terminal activation domain and referred to here as pUL48 − AD)
were used as bait in an attempt to avoid previously observed
autoactivation by full-length pUL48 (Douglas et al., 2004; Vittone et
al., 2005). Amino acids 1–411 contain the core of pUL48 whose
structure has been identiﬁed as containing regions sufﬁcient for
virion assembly (Liu et al., 1999). Unfortunately though strong
autoactivation was still observed for Bait pUL48 − AD (Table 2). The
majority of those HSV-1 proteins which did autoactivate as baits
could at least be tested in the reverse orientation as a target fusion
construct. The exception was the envelope protein gE which
autoactivates as bait and is not expressed as target (Table 1).
Autoactivation has been previously documented for PrV gE
cytoplasmic tail (Fuchs et al., 2002). Indeed a large proportion of
the envelope proteins either autoactivated as baits or were not
expressed as targets which partly explains why so few interactions
involving envelope proteins were identiﬁed (Table 1).
Quantitative β-galactosidase activity values were then obtained
for each positive interaction using a liquid assay (Table 3). All values
were less than the positive control of Bait p53/Target SV40 Large T-
antigen (Table 3). For a number of interactions the β-galactosidase
activity values were not signiﬁcantly above the negative control of
Bait no insert/Target no insert (Table 3). In most cases a reasonable
correlation was found between the intensity of blue colour
observed with the plate-based assay versus the β-galactosidase
activity values obtained using a quantitative liquid assay (Table 3).
Though there were some exceptions (Table 3). It should be noted
that the quantitative liquid assay only depends on activation of the
one reporter gene lacZ while the plate-based assay is more
stringent as it depends on activation of two reporter genes LEU2
and lacZ.
The expression of bait and target fusion constructs in the LexA
yeast two-hybrid assay was assessed by immunoblotting for either
the LexA tag (present in bait fusions) (Fig. 1) or the hemagglutinin
(HA) tag (present in target fusions) (Fig. 2). This was to establish that
any negative interaction was not the result of the absence of
expression in the yeast two-hybrid assay. The large majority of fusion
proteins were expressed with varying degrees of proteolysis (Figs. 1
and 2). Although a yeast protease inhibitor cocktail (Sigma product
number P8215) was included during sample extraction the observed
proteolysis most likely occurred during the extraction due to the
range of strong endogenous proteases in yeast. Although a number of
the bait proteins, particularly the tegument proteins pUL36N, pUL37,
pUL41, pUL46, pUL47 and pUL51, appear to be expressed at low levels
(Fig. 1), at least some of these, pUL36N, pUL37 and pUL46, were still
able to produce positive interactions in the yeast two-hybrid screen
(Table 2). These same tegument proteins were all well expressed as
targets (Fig. 2). This provided the opportunity to establish interac-
tions which may have not have been detected as baits due to the low
expression levels. The only bait fusion that was not expressed was
bait/pUL13 (not shown). A band for bait/pUL36N was not apparent in
the immunoblots (based on a predicted size of ∼200 kDa (Table 1) it
most likely did not migrate into the 12% gel) (Fig. 1) but interactions
were observed with this construct (Table 2). In the case of targetfusions the cytoplasmic tails of gC, gD, gE and pUS9 were not
expressed (Fig. 2).
Discussion
In this study we have identiﬁed a number of binary interactions
involving HSV-1 structural proteins using the LexA yeast two-hybrid
matrix screen (Tables 1 and 2). Although the yeast two-hybrid
approach is a relatively straightforward way to screen for large
numbers of protein interactions, like any approach it does have some
limitations (Diefenbach et al., 2005). Even related yeast two-hybrid
Fig. 1. Expression of bait/HSV-1 structural proteins in yeast. Yeast mated with various combinations of Bait and Target fusion constructs were subjected to protein extraction before
separation by SDS-PAGE (12%). Immunoblot with anti-LexA showing expression of Bait fusion constructs. The positions of the fusion protein based on predicted molecular weights
(Table 1) are indicated (⁎). The common bands observed in each lane reﬂect non-speciﬁc detection by the primary antibody as observed with Bait only (not shown). The speciﬁc
multiple bands observed in most lanes are due to proteolysis. UD, upper domain of pUL19; N, aa 1–1874; CT, cytoplasmic tail.
351J.H. Lee et al. / Virology 378 (2008) 347–354approaches do not usually give rise to the same results (Uetz et al.,
2006). This study though does represent one of the few proteomics-
based approaches to the study of viral structural biology and only the
second such approach for an alphaherpesvirus, the other being for VZV
(Uetz et al., 2006). Whether the identiﬁed interactions are structural,
regulatory or other requires further elucidation. However, from the
work of others and the current model for viral assembly (Mettenleiter
et al., 2006; Mettenleiter, 2006) a number of the observed interactions
are likely to be important for assembly.
Capsid–capsid interactions
Of the 6 capsid–capsid interactions identiﬁed (Table 2), 3 have
been previously identiﬁed. This includes the interaction of the triplex-
forming capsid proteins pUL18 and pUL38, which plays an essential
role in capsid assembly and architecture (Desai and Person, 1996;
Zhou et al., 2000; Adamson et al., 2006; Okoye et al., 2006). The self-
association of pUL18 has been previously described and appears to be
an intermediate in the formation of capsid triplexes (consist of 1 copy
of pUL38 and 2 copies of pUL18) (Spencer et al., 1998). The interaction
between pUL19 UD and pUL35 has also been documented, though this
interaction is not essential for capsid assembly (Chen et al., 2001;
Bowman et al., 2003; Baker et al., 2006). Novel interactions identiﬁed
in this study include pUL35–pUL18, pUL35–pUL25 and pUL35–pUL38.
The precise role of these interactions in capsid assembly requires
further investigation. In the case of pUL35–pUL18 and pUL35–pUL38
they are unlikely to be directly involved given the architecture of thecapsid (Zhou et al., 2000). In addition, these interactions were not
identiﬁed in a previous investigation of the pairwise interactions
required for transport of capsid assembly intermediates into the
nucleus, the ﬁnal site of capsid assembly (Rixon et al., 1996).
Nevertheless, the possibility still exists that these interactions may
contribute to nuclear localization of one or both of the interacting
partners.
Capsid–tegument interactions
A total of 16 interactions were identiﬁed involving capsid and
tegument proteins (Table 2). Of these interactions half involved the
capsid protein pUL35. The relative importance of these interactions in
viral assembly needs further investigation. Deletion of pUL35 appears
to not have any signiﬁcant effect on tegumentation of the capsid (Chen
et al., 2001). In addition, deletion of pUL35 has no signiﬁcant effect on
viral replication in cell lines but does appear to play a role in virion
productionwhen tested in mouse ganglia (Desai et al., 1998). Only 2 of
the identiﬁed capsid–tegument interactions have been documented
elsewhere. Interaction of HSV-2 capsid protein pUL35 with tegument
proteins pUL14 has been suggested on the basis of a cellular
relocalization assay and as such likely plays a non-structural role
(Yamauchi et al., 2001). Interaction of capsid protein pUL35 with
tegument protein pUL37 has also been reported for VZV (Uetz et al.,
2006). The interaction of both the tegument proteins pUL37 and
pUL48 with pUL35 may provide additional attachment of the
tegument to the capsid via the hexons. Additional tegument–capsid
Fig. 2. Expression of target/HSV-1 structural proteins in yeast. Yeast mated with various combinations of Bait and Target fusion constructs were subjected to protein extraction before
separation by SDS-PAGE (12%). Immunoblot with anti-HA showing expression of Target fusion constructs. The positions of the fusion protein based on predicted molecular weights
(Table 1) are indicated (⁎). The speciﬁc multiple bands observed in most lanes are due to proteolysis. UD, upper domain of pUL19; N1, aa 1–767; CT, cytoplasmic tail.
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with pUL18 and pUL21 with pUL19. The reported complex of the
capsid protein pUL25 and the tegument protein pUL17 (Trus et al.,
2007) could not be assessed in this study due to autoactivation by both
proteins as baits (Table 1). Another reported interaction of the capsid
protein pUL25 and the tegument protein pUL36 in PrV (Coller et al.,
2007) and VZV (Uetz et al., 2006) could not be veriﬁed in this study.
This is because the interaction depends on the C-terminus of pUL36
(Coller et al., 2007) which was absent from the pUL36 fragments
tested in the current yeast two-hybrid screen.
Tegument–tegument interactions
A total of 15 interactions between tegument proteins were
identiﬁed (Table 2). Of these interactions, 9 were identiﬁed previously
in our laboratory (Vittone et al., 2005). These included pUL11–pUL16,
pUL36–pUL37, pUL36–pUL48, pUL37–pUL36, pUL37–pUL37, pUL46–
pUL48, pUL49–pUL48, pUL49–pUL49 and pUS11–pUS11. The only
interaction not conﬁrmed was that of pUL47 and pUL48 which in our
original screen was one of the weakest interactions (Vittone et al.,
2005). It may not have been detected in this current study as the
interactions were determined in diploid yeast, a result of yeast mating,
rather than haploid yeast. As these interactions have been discussed
previously (Vittone et al., 2005) we will only touch on the pUL36–
pUL37 interaction here. This interaction between two essential
tegument proteins has now been conﬁrmed in a number of herpes-viruses including HSV-1 (Vittone et al., 2005), PrV (Klupp et al., 2002),
VZV (Uetz et al., 2006) and Kaposi’s Sarcoma-associated virus (Rozen
et al., 2008). For HSV-1, the interaction has also been further deﬁned at
the amino acid level (Mijatov et al., 2007) and although deletion of the
pUL37-binding site in PrV pUL36 does not completely block viral
assembly (Fuchs et al., 2004) it remains to be determined whether the
same phenotype occurs in HSV-1. The study with PrV did not show
whether blockage of pUL37 binding to pUL36 leads to loss of pUL37 in
assembled virions. As indicated above the observed interaction of
pUL35 with pUL37 may provide an alternative contact for binding of
pUL37 to the capsid, rather then via pUL36 which itself interacts with
pUL19 (McNabb and Courtney,1992; Baker et al., 2006). An interaction
was found between pUL46 and pUL37, at least in one orientation
(Table 2), which was not detected in our previous study (Vittone et al.,
2005). This interaction may be of signiﬁcance in providing a link
between the inner and outer tegument layers of HSV-1. An interaction
was identiﬁed between the protein kinase pUS3 and pUL46. The
reported viral protein substrates for HSV-1 pUS3 do not include
pUL46 (Kato et al., 2005). Whether this is a structural or regulatory
interaction requires further investigation.
Tegument–envelope and envelope–envelope interactions
A total of 3 new interactions were identiﬁed involving the
cytoplasmic tails of envelope proteins (Table 2). These included
pUL46–gM and pUS9–pUL49. These tegument–envelope interactions
353J.H. Lee et al. / Virology 378 (2008) 347–354are likely to be involved in the process of secondary envelopment
during viral assembly. A number of interactions, not detected in this
study, that likely play a role in secondary envelopment have been
previously reported between tegument proteins and cytoplasmic tails
of herpesviral glycoproteins. These include pUL48 with gH (Gross et
al., 2003), and pUL49 with gE/gI, gM and gD (Fuchs et al., 2002;
Farnsworth et al., 2007; O’Regan et al., 2007). The reasons these
interactions were not detected include the absence of gH from the
current screen, autoactivation or lack of expression of gE resulting in
exclusion from the current screen. In addition, expression of the
cytoplasmic tails of the envelope proteins alone would not have
detected interactions that depend on oligomerization via the envelope
protein’s transmembrane domains or prior complex formation
between different envelope proteins. One self-association was
observed between the cytoplasmic tails of gB (Table 2). The precise
role of such an interaction is not clear. The dimerization of gB has been
previously reported and although it did not require the cytoplasmic
tail the possible dimerization of the tail alone was never directly
assessed (Laquerre et al., 1996).
Knowledge of HSV-1 structural protein–protein interactions will
provide insights into the pathways of viral assembly and the identiﬁed
interactions will permit the design and/or identiﬁcation of candidate
antiviral agents for treatment of neurotropic virus infections,
particularly alphaherpesvirus infections. Our strategy to target sites
of viral structural protein assembly provides an alternative to the
current focus of drug development which is based on identifying
inhibitors of speciﬁc HSV-1 enzymes such as DNA polymerase,
ribonucleotide reductase and proteases (Naesens and De Clercq,
2001). The use of complementary approaches to conﬁrm the yeast
two-hybrid interactions and to look for higher order complexes (yeast
two-hybrid assay only detects binary interactions) is currently
underway. To do so we are in the process of generating HSV-1
constructs with afﬁnity tags on individual key viral proteins such as
pUL36, pUL37 or pUL48. These tags will be exploited to isolate protein
complexes, dependent on the tagged protein, under native conditions
from infected cells at various time points post-infection. Information
on higher order protein complexes would not only shed light on
intermediate complexes formed during viral assembly but may also
reveal the role of cellular proteins in this process.
Materials and methods
Expression constructs
The cloning of HSV-1 capsid genes (UL6, UL18, UL25, UL35 and
UL38) and tegument genes (UL11, UL14, UL16, UL17, UL21, UL36,
UL37, UL41, UL46, UL48, UL49 and US11) into the yeast two-hybrid
vectors displayBait and displayTarget (Display Systems Biotech) has
been previously described (Douglas et al., 2004; Vittone et al., 2005).
Additional HSV-1 genes cloned in this study included the capsid gene
UL19, the 7 tegument genes UL4, UL13, UL51, UL56, US2, US3 and
US10 and the 8 envelope genes gM, gB, gC, UL45, gD, gI, gE and US9.
In the case of each envelope gene only the cytoplasmic tail was
cloned (Table 1). Each viral gene was ampliﬁed from a HSV-1 strain
17 cosmid library (kindly provided by Charles Cunningham, MRC,
Glasgow) (Cunningham and Davison, 1993) before insertion into
either EcoRI digested (for UL51 and US3) or EcoRI/XhoI digested (for
the reminder) displayBait or displayTarget, as previously described
(Douglas et al., 2004; Vittone et al., 2005). Gateway™ cloning
technology (Invitrogen) was used for the region of UL19 gene
corresponding to the upper domain (amino acids 451–1054) (Bow-
man et al., 2003). A CACC motif was engineered into the 5′ end of the
forward primer, to enable base pairing with the GTGG overhang
in the entry vector pENTR™/D-TOPO® vector (Invitrogen). The
UL19 gateway entry clone was then used to introduce the UL19
upper domain insert into either displayBait or displayTarget that hadbeen made compatible with the gateway system using a Gateway™
vector conversion system (Invitrogen).
Yeast two-hybrid assay
The use of the LexA-based yeast two-hybrid assay has been
previously described (Douglas et al., 2004; Vittone et al., 2005).
However, to facilitate high throughput the yeast two-hybrid assay was
modiﬁed to incorporate yeast mating. Brieﬂy, two mating strains of
haploid yeast were used. The Saccharomyces cerevisiae MATα strain
EGY48 (Clontech) was transformed with both the displayBait
construct and the reporter plasmid pSH18–34 (Invitrogen) whereas
the S. cerevisiae MATa strain YM4271 (Clontech) was transformed with
the displayTarget construct. Single transformants were subsequently
picked from appropriate selection agar plates and resuspended in 1ml
of liquid YPD. Then 20 μl of the cell suspension for each haploid strain
was aliquoted in the same well of a 96 well plate containing 160 μl of
liquid YPD. The 96 well plate was incubated at 30 °C for 18 h to allow
enough time for the haploid cells to fuse and become diploid cells
containing displayBait and displayTarget constructs as well as the
reporter plasmid. After incubation, 100 μl of diploid yeast cells were
plated out on master agar plates. The protocols for qualitative
assessment of protein–protein interactions, quantiﬁcation of each
positive interaction using a β-galactosidase assay and determination
of protein expression in yeast were then as previously described
(Douglas et al., 2004; Vittone et al., 2005). The β-galactosidase activity
was calculated from the following equation: β-galactosidase
activity=1000×A420/(t×V×OD660) where t=time (min) of incubation
and V=volume of cells (ml) used in the assay. The values obtained for
β-galactosidase activity were the average of measurements from three
separate colonies.
Analysis of protein expression
Proteins were separated by SDS-PAGE and for analysis of expres-
sion in yeast were processed as previously described (Diefenbach et
al., 1998; Vittone et al., 2005). Detection was performed with an
Odyssey Infra-red Imaging system (Licor-Biosciences). Primary anti-
bodies used included mouse monoclonal antibody against HA (1:500
dilution; Santa Cruz Biotechnology) and rabbit polyclonal against LexA
(1:500 dilution; Sigma). Secondary antibodies for the Odyssey system
included goat anti-mouse Alexa Fluor 680-conjugated IgG (used at
1:5000 dilution; Molecular Probes) and goat anti-rabbit IRdye800-
conjugated IgG (used at 1:5000 dilution; Rockland Inc.).
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